Red Clover Extract
•Last Updated: September 28 2022
Red Clover Extract (Promensil or Menoflavon) are isoflavones including the soy isoflavones in low amounts and some similar structures such as Biochanin A; used as a therapy for menopause, red clover appears to have minor yet unreliable benefits in improving health and reducing hot flashes.
Red Clover Extract is most often used for
Last Updated: September 28 2022
Red Clover Extract (RCE) refers to any extract that is taken from the red clover plant, known botanically as trifolium pratense which is a good natural source of isoflavone molecules. There are a few brand name products of RCE (Promensil, Menoflavon, etc.) which isolate the isoflavones that are thought to be bioactive, and this mainly refers to two of the soy isoflavones which are also found in this plant (genistein and daidzein) and two structurally similar methylated isoflavones known as biochanin A and formononetin. Specifically, biochanin A is just methylated genistein (and can produce genistein in the body when it is ingested) whereas formononetin is methylated daidzein (can also produce daidzein in the body after ingestion). RCE, and its brand name products, are recommended for the treatment of menopause or asthmatic symptoms.
When looking at research on RCE and menopausal symptoms, there are indeed benefits in isolated studies relative to placebo but there are also many failures indicating that supplementation is pretty unreliable in benefitting symptoms; this may be in part due to differences in absorption or simply due to potential industry bias (since many studies using the brand name products are partially funded by the producers of the products, and the independent studies tend to be more likely to report no significant benefit). There may be a minor reduction in anxiety however, which would be a percievable benefit and needs to be further evaluated. It should also be noted that most studies do reported great benefit with supplementation, but the placebo effect per se is very prominent in studies on menopausal symptoms (case in point, studies on black cohosh where the placebo effect sometimes halves symptoms of menopause alone).
Beyond the above possible anxiolytic property of red clover that needs to be investigated further and a possibly benefit to asthma and cough (also needs to be investigated further), there does not appear to be any significant benefit associated with red clover extract.
Note that Red Clover Extract is also known as:
- trifolium pratense
- biochanin A
- Formononetin Promensil (brand name)
- Menoflavon (brand name)
Supplementation of Red Clover Extract tends to be 40mg of total isoflavones taken once a day, or two doses totalling 80mg a day. This can be reached through:
- Supplementing pure isoflavones (in which case the range is 40-80mg)
- Supplementing brand name products such as Promensil, which confer 40mg isoflavones per 500mg capsule (so, around 8% isoflavones by weight)
- Approximately 5 grams of the whole plant without any particular extraction techniques
What works and what doesn't?
Unlock the full potential of Examine
Latest ResearchRead all studies
1.^Engelmann NJ, Reppert A, Yousef G, Rogers RB, Lila MAIn Vitro Production of Radiolabeled Red Clover (Trifolium pratense) IsoflavonesPlant Cell Tissue Organ Cult.(2009 May 26)
2.^Cassidy A, Bingham S, Setchell KDBiological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal womenAm J Clin Nutr.(1994 Sep)
3.^Ko WC, Lin LH, Shen HY, Lai CY, Chen CM, Shih CHBiochanin a, a phytoestrogenic isoflavone with selective inhibition of phosphodiesterase 4, suppresses ovalbumin-induced airway hyperresponsivenessEvid Based Complement Alternat Med.(2011)
4.^Wu Q, Wang M, Simon JEDetermination of isoflavones in red clover and related species by high-performance liquid chromatography combined with ultraviolet and mass spectrometric detectionJ Chromatogr A.(2003 Oct 24)
5.^Atkinson C, Warren RM, Sala E, Dowsett M, Dunning AM, Healey CS, Runswick S, Day NE, Bingham SARed-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial {ISRCTN42940165}Breast Cancer Res.(2004)
6.^van de Weijer PH, Barentsen RIsoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placeboMaturitas.(2002 Jul 25)
7.^Baber RJ, Templeman C, Morton T, Kelly GE, West LRandomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in womenClimacteric.(1999 Jun)
8.^Knight DC, Howes JB, Eden JAThe effect of Promensil, an isoflavone extract, on menopausal symptomsClimacteric.(1999 Jun)
9.^Vrieling A, Rookus MA, Kampman E, Bonfrer JM, Korse CM, van Doorn J, Lampe JW, Cats A, Witteman BJ, van Leeuwen FE, van't Veer LJ, Voskuil DWIsolated isoflavones do not affect the circulating insulin-like growth factor system in men at increased colorectal cancer riskJ Nutr.(2007 Feb)
10.^Vrieling A, Rookus MA, Kampman E, Bonfrer JM, Bosma A, Cats A, van Doorn J, Korse CM, Witteman BJ, van Leeuwen FE, van't Veer LJ, Voskuil DWNo effect of red clover-derived isoflavone intervention on the insulin-like growth factor system in women at increased risk of colorectal cancerCancer Epidemiol Biomarkers Prev.(2008 Oct)
11.^Schult TM, Ensrud KE, Blackwell T, Ettinger B, Wallace R, Tice JAEffect of isoflavones on lipids and bone turnover markers in menopausal womenMaturitas.(2004 Jul 15)
12.^Nestel PJ, Pomeroy S, Kay S, Komesaroff P, Behrsing J, Cameron JD, West LIsoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal womenJ Clin Endocrinol Metab.(1999 Mar)
13.^Teede HJ, McGrath BP, DeSilva L, Cehun M, Fassoulakis A, Nestel PJIsoflavones reduce arterial stiffness: a placebo-controlled study in men and postmenopausal womenArterioscler Thromb Vasc Biol.(2003 Jun 1)
14.^Chedraui P, Hidalgo L, San Miguel G, Morocho N, Ross SRed clover extract (MF11RCE) supplementation and postmenopausal vaginal and sexual healthInt J Gynaecol Obstet.(2006 Dec)
15.^Wang Y, Man Gho W, Chan FL, Chen S, Leung LKThe red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expressionBr J Nutr.(2008 Feb)
16.^Tolleson WH, Doerge DR, Churchwell MI, Marques MM, Roberts DWMetabolism of biochanin A and formononetin by human liver microsomes in vitroJ Agric Food Chem.(2002 Aug 14)
17.^Roberts DW, Doerge DR, Churchwell MI, Gamboa da Costa G, Marques MM, Tolleson WHInhibition of extrahepatic human cytochromes P450 1A1 and 1B1 by metabolism of isoflavones found in Trifolium pratense (red clover)J Agric Food Chem.(2004 Oct 20)
18.^Nestel P, Cehun M, Chronopoulos A, DaSilva L, Teede H, McGrath BA biochanin-enriched isoflavone from red clover lowers LDL cholesterol in menEur J Clin Nutr.(2004 Mar)
19.^van Meeuwen JA, Korthagen N, de Jong PC, Piersma AH, van den Berg M(Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-cultureToxicol Appl Pharmacol.(2007 Jun 15)
20.^Jeong HJ, Shin YG, Kim IH, Pezzuto JMInhibition of aromatase activity by flavonoidsArch Pharm Res.(1999 Jun)
21.^Kao YC, Zhou C, Sherman M, Laughton CA, Chen SMolecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis studyEnviron Health Perspect.(1998 Feb)
22.^Orr A, Parker RRed clover causing symptoms suggestive of methotrexate toxicity in a patient on high-dose methotrexateMenopause Int.(2013 Sep)
23.^VanWert AL, Sweet DHImpaired clearance of methotrexate in organic anion transporter 3 (Slc22a8) knockout mice: a gender specific impact of reduced folatesPharm Res.(2008 Feb)
24.^Vlaming ML, van Esch A, van de Steeg E, Pala Z, Wagenaar E, van Tellingen O, Schinkel AHImpact of abcc2 {multidrug resistance-associated protein (MRP) 2}, abcc3 (MRP3), and abcg2 (breast cancer resistance protein) on the oral pharmacokinetics of methotrexate and its main metabolite 7-hydroxymethotrexateDrug Metab Dispos.(2011 Aug)
25.^Breedveld P, Zelcer N, Pluim D, Sönmezer O, Tibben MM, Beijnen JH, Schinkel AH, van Tellingen O, Borst P, Schellens JHMechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles: potential role for breast cancer resistance protein in clinical drug-drug interactionsCancer Res.(2004 Aug 15)
26.^Barnhart K, Coutifaris C, Esposito MThe pharmacology of methotrexateExpert Opin Pharmacother.(2001 Mar)
27.^Geller SE, Shulman LP, van Breemen RB, Banuvar S, Zhou Y, Epstein G, Hedayat S, Nikolic D, Krause EC, Piersen CE, Bolton JL, Pauli GF, Farnsworth NRSafety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomized controlled trialMenopause.(2009 Nov-Dec)
28.^Lipovac M, Chedraui P, Gruenhut C, Gocan A, Stammler M, Imhof MImprovement of postmenopausal depressive and anxiety symptoms after treatment with isoflavones derived from red clover extractsMaturitas.(2010 Mar)
29.^Lipovac M, Chedraui P, Gruenhut C, Gocan A, Kurz C, Neuber B, Imhof MEffect of Red Clover Isoflavones over Skin, Appendages, and Mucosal Status in Postmenopausal WomenObstet Gynecol Int.(2011)
30.^Ehsanpour S, Salehi K, Zolfaghari B, Bakhtiari SThe effects of red clover on quality of life in post-menopausal womenIran J Nurs Midwifery Res.(2012 Jan)
31.^Howes JB, Bray K, Lorenz L, Smerdely P, Howes LGThe effects of dietary supplementation with isoflavones from red clover on cognitive function in postmenopausal womenClimacteric.(2004 Mar)
32.^Howes JB, Tran D, Brillante D, Howes LGEffects of dietary supplementation with isoflavones from red clover on ambulatory blood pressure and endothelial function in postmenopausal type 2 diabetesDiabetes Obes Metab.(2003 Sep)
33.^Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, Yasuda KSoy product intake is inversely associated with serum homocysteine level in premenopausal Japanese womenJ Nutr.(2003 Mar)
34.^Samman S, Koh HS, Flood VM, Blakesmith SJ, Petocz P, Lyons-Wall PMRed clover (Trifolium pratense) isoflavones and serum homocysteine in premenopausal women: a pilot studyJ Womens Health (Larchmt).(2009 Nov)
35.^Hidalgo LA, Chedraui PA, Morocho N, Ross S, San Miguel GThe effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double-blind, placebo-controlled studyGynecol Endocrinol.(2005 Nov)
36.^Howes JB, Sullivan D, Lai N, Nestel P, Pomeroy S, West L, Eden JA, Howes LGThe effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemiaAtherosclerosis.(2000 Sep)
37.^Atkinson C, Oosthuizen W, Scollen S, Loktionov A, Day NE, Bingham SAModest protective effects of isoflavones from a red clover-derived dietary supplement on cardiovascular disease risk factors in perimenopausal women, and evidence of an interaction with ApoE genotype in 49-65 year-old womenJ Nutr.(2004 Jul)
38.^Chedraui P, San Miguel G, Hidalgo L, Morocho N, Ross SEffect of Trifolium pratense-derived isoflavones on the lipid profile of postmenopausal women with increased body mass indexGynecol Endocrinol.(2008 Nov)
39.^Blakesmith SJ, Lyons-Wall PM, George C, Joannou GE, Petocz P, Samman SEffects of supplementation with purified red clover (Trifolium pratense) isoflavones on plasma lipids and insulin resistance in healthy premenopausal womenBr J Nutr.(2003 Apr)
40.^Chan MY, Wai Man G, Chen ZY, Wang J, Leung LKOestrogen receptor alpha is required for biochanin A-induced apolipoprotein A-1 mRNA expression in HepG2 cellsBr J Nutr.(2007 Sep)
41.^Harnish DC, Evans MJ, Scicchitano MS, Bhat RA, Karathanasis SKEstrogen regulation of the apolipoprotein AI gene promoter through transcription cofactor sharingJ Biol Chem.(1998 Apr 10)
42.^Yuen YM, Leung LKGenistein and daidzein induced apoA-1 transactivation in hepG2 cells expressing oestrogen receptor-alphaBr J Nutr.(2008 May)
43.^Campbell MJ, Woodside JV, Honour JW, Morton MS, Leathem AJEffect of red clover-derived isoflavone supplementation on insulin-like growth factor, lipid and antioxidant status in healthy female volunteers: a pilot studyEur J Clin Nutr.(2004 Jan)
44.^Clifton-Bligh PB, Baber RJ, Fulcher GR, Nery ML, Moreton TThe effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolismMenopause.(2001 Jul-Aug)
45.^Terzic MM, Dotlic J, Maricic S, Mihailovic T, Tosic-Race BInfluence of red clover-derived isoflavones on serum lipid profile in postmenopausal womenJ Obstet Gynaecol Res.(2009 Dec)
46.^Anderson JW, Johnstone BM, Cook-Newell MEMeta-analysis of the effects of soy protein intake on serum lipidsN Engl J Med.(1995 Aug 3)
47.^Lee CC, Bloem CJ, Kasa-Vubu JZ, Liang LJEffect of oral phytoestrogen on androgenicity and insulin sensitivity in postmenopausal womenDiabetes Obes Metab.(2012 Apr)
48.^Su SJ, Yeh YT, Su SH, Chang KL, Shyu HW, Chen KM, Yeh HBiochanin a promotes osteogenic but inhibits adipogenic differentiation: evidence with primary adipose-derived stem cellsEvid Based Complement Alternat Med.(2013)
49.^Atkinson C, Compston JE, Day NE, Dowsett M, Bingham SAThe effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trialAm J Clin Nutr.(2004 Feb)
50.^Kawakita S, Marotta F, Naito Y, Gumaste U, Jain S, Tsuchiya J, Minelli EEffect of an isoflavones-containing red clover preparation and alkaline supplementation on bone metabolism in ovariectomized ratsClin Interv Aging.(2009)
51.^Occhiuto F, Pasquale RD, Guglielmo G, Palumbo DR, Zangla G, Samperi S, Renzo A, Circosta CEffects of phytoestrogenic isoflavones from red clover (Trifolium pratense L.) on experimental osteoporosisPhytother Res.(2007 Feb)
52.^Kaczmarczyk-Sedlak I, Wojnar W, Zych M, Ozimina-Kamińska E, Taranowicz J, Siwek AEffect of formononetin on mechanical properties and chemical composition of bones in rats with ovariectomy-induced osteoporosisEvid Based Complement Alternat Med.(2013)
53.^Giguère V, Yang N, Segui P, Evans RMIdentification of a new class of steroid hormone receptorsNature.(1988 Jan 7)
54.^Eudy JD, Yao S, Weston MD, Ma-Edmonds M, Talmadge CB, Cheng JJ, Kimberling WJ, Sumegi JIsolation of a gene encoding a novel member of the nuclear receptor superfamily from the critical region of Usher syndrome type IIa at 1q41Genomics.(1998 Jun 15)
55.^Greschik H, Wurtz JM, Sanglier S, Bourguet W, van Dorsselaer A, Moras D, Renaud JPStructural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3Mol Cell.(2002 Feb)
56.^Chen S, Zhou D, Yang C, Sherman MMolecular basis for the constitutive activity of estrogen-related receptor alpha-1J Biol Chem.(2001 Jul 27)
57.^Suetsugi M, Su L, Karlsberg K, Yuan YC, Chen SFlavone and isoflavone phytoestrogens are agonists of estrogen-related receptorsMol Cancer Res.(2003 Nov)
58.^Ariazi EA, Clark GM, Mertz JEEstrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancerCancer Res.(2002 Nov 15)
59.^Rosenberg Zand RS, Jenkins DJ, Diamandis EPEffects of natural products and nutraceuticals on steroid hormone-regulated gene expressionClin Chim Acta.(2001 Oct)
60.^Lutter S, Schmalbach K, Esch HL, Lehmann LThe isoflavone irilone contributes to the estrogenic potential of dietary supplements containing red cloverArch Toxicol.(2013 Aug 28)
61.^Hale GE, Hughes CL, Robboy SJ, Agarwal SK, Bievre MA double-blind randomized study on the effects of red clover isoflavones on the endometriumMenopause.(2001 Sep-Oct)
62.^Powles TJ, Howell A, Evans DG, McCloskey EV, Ashley S, Greenhalgh R, Affen J, Flook LA, Tidy ARed clover isoflavones are safe and well tolerated in women with a family history of breast cancerMenopause Int.(2008 Mar)
63.^Imhof M, Gocan A, Reithmayr F, Lipovac M, Schimitzek C, Chedraui P, Huber JEffects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal womenMaturitas.(2006 Aug 20)
64.^Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KEThe effects of insulin-like growth factors on tumorigenesis and neoplastic growthEndocr Rev.(2000 Jun)
65.^Voskuil DW, Vrieling A, van't Veer LJ, Kampman E, Rookus MAThe insulin-like growth factor system in cancer prevention: potential of dietary intervention strategiesCancer Epidemiol Biomarkers Prev.(2005 Jan)
66.^Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger MInsulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysisLancet.(2004 Apr 24)
67.^Morris JK, George LM, Wu T, Wald NJInsulin-like growth factors and cancer: no role in screening. Evidence from the BUPA study and meta-analysis of prospective epidemiological studiesBr J Cancer.(2006 Jul 3)
68.^Wei EK, Ma J, Pollak MN, Rifai N, Fuchs CS, Hankinson SE, Giovannucci EA prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in womenCancer Epidemiol Biomarkers Prev.(2005 Apr)
69.^Kaaks R, Toniolo P, Akhmedkhanov A, Lukanova A, Biessy C, Dechaud H, Rinaldi S, Zeleniuch-Jacquotte A, Shore RE, Riboli ESerum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in womenJ Natl Cancer Inst.(2000 Oct 4)
70.^Xu Z, Maroney AC, Dobrzanski P, Kukekov NV, Greene LAThe MLK family mediates c-Jun N-terminal kinase activation in neuronal apoptosisMol Cell Biol.(2001 Jul)
71.^Figueroa C, Tarras S, Taylor J, Vojtek ABAkt2 negatively regulates assembly of the POSH-MLK-JNK signaling complexJ Biol Chem.(2003 Nov 28)
72.^Lim TG, Kim JE, Jung SK, Li Y, Bode AM, Park JS, Yeom MH, Dong Z, Lee KWMLK3 is a direct target of biochanin A, which plays a role in solar UV-induced COX-2 expression in human keratinocytesBiochem Pharmacol.(2013 Oct 1)
73.^Lin VC, Ding HY, Tsai PC, Wu JY, Lu YH, Chang TSIn vitro and in vivo melanogenesis inhibition by biochanin A from Trifolium pratenseBiosci Biotechnol Biochem.(2011)
74.^Lipovac M, Chedraui P, Gruenhut C, Gocan A, Kurz C, Neuber B, Imhof MThe effect of red clover isoflavone supplementation over vasomotor and menopausal symptoms in postmenopausal womenGynecol Endocrinol.(2012 Mar)
75.^del Giorno C, Fonseca AM, Bagnoli VR, Assis JS, Soares JM Jr, Baracat ECEffects of Trifolium pratense on the climacteric and sexual symptoms in postmenopause womenRev Assoc Med Bras.(2010 Sep-Oct)
76.^Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SRPhytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trialJAMA.(2003 Jul 9)
77.^Ko WC, Shih CM, Lai YH, Chen JH, Huang HLInhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationshipsBiochem Pharmacol.(2004 Nov 15)
78.^Kim E, Chun HO, Jung SH, Kim JH, Lee JM, Suh BC, Xiang MX, Rhee CKImprovement of therapeutic index of phosphodiesterase type IV inhibitors as anti-AsthmaticsBioorg Med Chem Lett.(2003 Jul 21)
79.^Brueggemeier RW, Hackett JC, Diaz-Cruz ESAromatase inhibitors in the treatment of breast cancerEndocr Rev.(2005 May)
80.^Maskarinec G, Williams AE, Carlin LMammographic densities in a one-year isoflavone interventionEur J Cancer Prev.(2003 Apr)
81.^Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DFA systematic review of genetic polymorphisms and breast cancer riskCancer Epidemiol Biomarkers Prev.(1999 Oct)
82.^Chen HQ, Wang XJ, Jin ZY, Xu XM, Zhao JW, Xie ZJProtective effect of isoflavones from Trifolium pratense on dopaminergic neuronsNeurosci Res.(2008 Oct)
83.^Chen HQ, Jin ZY, Li GHBiochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage through inhibition of microglia activation and proinflammatory factors generationNeurosci Lett.(2007 May 1)
84.^Datla KP, Zbarsky V, Rai D, Parkar S, Osakabe N, Aruoma OI, Dexter DTShort-term supplementation with plant extracts rich in flavonoids protect nigrostriatal dopaminergic neurons in a rat model of Parkinson's diseaseJ Am Coll Nutr.(2007 Aug)
85.^Loing E, Lachance R, Ollier V, Hocquaux MA new strategy to modulate alopecia using a combination of two specific and unique ingredientsJ Cosmet Sci.(2013 Jan-Feb)
Primary Use